Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis: Case report

Journal of Neurosurgery

Volumn 96, Issue 5, 2002, Pages 946-948

  Gerlach, Rüdiger ^a   Marquardt, Gerhard ^a   Wissing, Heimo ^a   Scharrer, Inge ^a   Raabe, Andreas ^a   Seifert, Volker ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Coagulation; Factor VII; Hemostasis; Recombinant activated factor VII

Indexed keywords

FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TEST; CASE REPORT; COMPRESSION THERAPY; FEMALE; HEMANGIOPERICYTOMA; HEMOSTASIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKULL BASE TUMOR; SURGICAL TECHNIQUE;

EID: 0036233771     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2002.96.5.0946     Document Type: Article

References (13)

1. Effect of the administration of recombinant activated factor VII (recombinant activated factor VII; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
2. The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: The PROSE study
3. Recombinant activated factor VII as a universal haemostatic agent
4. Recombinant coagulation factor VIIa: From the concept to clinical application in hemophilia treatment in 2000
5. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: A pilot study
6. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII
7. Activated factor VII activates factors IX and X on the surface of activated platelets: Thoughts on the mechanism of action of high-dose activated factor VII
8. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia
9. Recombinant activated factor VII for adjunctive hemorrhage control in trauma
10. The factor VII-platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia
11. Potential role of NovoSeven in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage
12. Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII
13. Successful use of recombinant FVIIa (Novoseven) in the management of intractable post-surgical intra-abdominal haemorrhage